【上药控股与安斯泰来达成战略合作】金十数据4月11日讯,从上海医药获悉,4月10日,上药控股与安斯泰来举行战略合作签约仪式。双方将围绕安斯泰来新品“注射用佐妥昔单抗”在中国大陆的商业上市开展全面深入合作。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.